FTO exerted a tumor-suppressing effect in thyroid cancer (Huang et al., 2022[92]; Ji et al., 2022[98]) and cholangiocarcinoma (Gao et al., 2021[59]; Rong et al., 2019[202]). The gene discussed is FTO; the disease is thyroid cancer.